InvestSMART

Nova Eye Medical Limited (ASX: EYE) - Announcements

Current share price for EYE : $0.155 0.005 (3.33%)+

ASX company news and announcements for Nova Eye Medical Limited (EYE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nova Eye Medical Limited (EYE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nova Eye Medical Limited (EYE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nova Eye Medical Limited (EYE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$44 Reinstatement to Quotation 2 Mar 2023 8:59AM $0.230 $0.155 fallen by 32.61%
$44 Investor Presentation 2 Mar 2023 8:59AM $0.230 $0.155 fallen by 32.61%
$44 Nova Eye Completes Placement 2 Mar 2023 8:59AM $0.230 $0.155 fallen by 32.61%
$44 Suspension from Official Quotation 1 Mar 2023 8:02AM $0.230 $0.155 fallen by 32.61%
$44 Half Year Accounts 1 Mar 2023 8:02AM $0.230 $0.155 fallen by 32.61%
$44 Trading Halt 27 Feb 2023 9:06AM $0.230 $0.155 fallen by 32.61%
$44 Glaucoma Surgical Devices Sales Update 30 Jan 2023 7:18PM $0.245 $0.155 fallen by 36.73%
$44 Notification of cessation of securities - EYE 27 Jan 2023 12:56PM $0.250 $0.155 fallen by 38%
$44 Additional Clinical Application for 2RT 25 Jan 2023 8:15AM $0.270 $0.155 fallen by 42.59%
$44 Status of MArket Clearance for iTrack Advance in the USA 12 Dec 2022 8:25AM $0.295 $0.155 fallen by 47.46%
$44 Application for quotation of securities - EYE 25 Nov 2022 11:11AM $0.280 $0.155 fallen by 44.64%
$44 AGM Voting Results 17 Nov 2022 2:58PM $0.280 $0.155 fallen by 44.64%
$44 AGM presentation 2022 17 Nov 2022 11:34AM $0.300 $0.155 fallen by 48.33%
$44 Clarification Glaucoma Surgical Devices Sales Update 16 Nov 2022 9:49AM $0.285 $0.155 fallen by 45.61%
$44 Glaucoma Surgical Devices Sales Update 16 Nov 2022 8:48AM $0.285 $0.155 fallen by 45.61%
$44 AlphRet Completes Initial Recruitment of Investigator Sites 24 Oct 2022 9:57AM $0.225 $0.155 fallen by 31.11%
$44 Notice of Annual General Meeting 2022 14 Oct 2022 11:20AM $0.285 $0.155 fallen by 45.61%
$44 Notification regarding unquoted securities - EYE 16 Sep 2022 2:44PM $0.250 $0.155 fallen by 38%
$44 Application for quotation of securities - EYE 16 Sep 2022 2:22PM $0.250 $0.155 fallen by 38%
$44 Notification regarding unquoted securities - EYE 16 Sep 2022 2:17PM $0.250 $0.155 fallen by 38%
$44 2RT Presentation Professor Robyn H Guymer 15 Sep 2022 8:29AM $0.250 $0.155 fallen by 38%
$44 Appendix 3Y T Spurling 14 Sep 2022 4:07PM $0.250 $0.155 fallen by 38%
$44 AGM Date and Directors Nominations 14 Sep 2022 10:36AM $0.250 $0.155 fallen by 38%
$44 2RT Webinar Professor Robyn H Guymer MMBBS, PHD 9 Sep 2022 3:18PM $0.240 $0.155 fallen by 35.42%
$44 Notification of cessation of securities - EYE 6 Sep 2022 9:32AM $0.260 $0.155 fallen by 40.38%

176 - 200 of 352 results

Page 8 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.